Pharmafile Logo
Pharmafocus logo
Advanced Search

Lemtrada

Showing 15 posts of 18 posts found.

credit_-_daniel_leal-olivas-afp

Use of Genzyme’s MS drug Lemtrada restricted under ongoing EMA safety review

April 16, 2019
Manufacturing and Production, Sales and Marketing EMA, Genzyme, Lemtrada, multiple sclerosis, pharma

The EMA has launched a review into Genzyme’s multiple sclerosis drug Lemtrada (alemtuzumab) after reports emerged of treatment-related safety issues …

News
whats_up_doc

Lemtrada shows clinical efficacy in multiple sclerosis in 10-year follow-up data

April 20, 2016
Research and Development, Sales and Marketing Lemtrada, Sanofi, alemtuzumab, multiple sclerosis, sanofi genzyme

Sanofi Genzyme has presented 10-year follow-up data on Lemtrada (alemtuzumab) which points to its efficacy in patients with relapsing-remitting multiple …

News
Genzyme

Genzyme’s Lemtrada shows five-year efficacy in extended trials

October 8, 2015
Research and Development Genzyme, Lemtrada, MS, RRMS, alemtuzumab, multiple sclerosis, relapsing-remitting multiple sclerosis

Sanofi’s subsidiary Genzyme has achieved positive data from an extension study of Lemtrada in patients with relapsing remitting multiple sclerosis …

News
Genzyme image

FDA green lights Lemtrada for MS

November 17, 2014
Sales and Marketing FDA, Genzyme, Lemtrada, MS, Sanofi, rems, tecfidera

The US FDA has approved Sanofi’s Lemtrada for multiple sclerosis, almost a year after rejecting the drug on concerns about …

News
Esbriet image

Shortlist announced for best new pharma product

June 24, 2014
Research and Development, Sales and Marketing Esbriet, InterMune, Lemtrada, Orphan, dificlir, innovative, pif, prix galion, selincro

Treatments for idiopathic pulmonary fibrosis, hepatic encephalopathy and meningococcal infection are among 14 new medicines shortlisted for the UK Prix …

News
sanofi image

Lemtrada resubmitted to FDA

June 2, 2014
Sales and Marketing FDA, Lemtrada, MS, Sanofi

Sanofi has resubmitted its application for Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis (MS) to the …

News
sanofi_building

Sanofi hit hard by Lemtrada rejection

January 2, 2014
Medical Communications, Research and Development, Sales and Marketing Aubagio, FDA, Genzyme, Lemtrada, MS, Sanofi

News
NICE image

NICE wants more Lemtrada data

December 6, 2013
Sales and Marketing Lemtrada, MS, NICE, Sanofi

NICE has said there are ‘still questions to be answered’ over Sanofi’s submission of its multiple sclerosis drug Lemtrada and …

News
Genzyme image

‘Fatal’ safety concerns throw doubt on Lemtrada

November 11, 2013
Research and Development, Sales and Marketing FDA, Genzyme, Lemtrada, MS, Sanofi

An FDA committee has dashed hopes of an approval for Sanofi’s multiple sclerosis drug after saying its benefits may not …

News
sanofi_chris_viehbacher

Sanofi’s Lemtrada given European go ahead

September 18, 2013
Research and Development, Sales and Marketing Aubagio, Lemtrada, MS, Sanofi, gilenya

News
Genzyme image

Sanofi’s Lemtrada nears EU approval

July 1, 2013
Sales and Marketing CHMP, Genzyme, Lemtrada, Sanofi

Sanofi’s multiple sclerosis drug Lemtrada has received a positive recommendation from the CHMP, meaning a European approval is likely just …

News

Sanofi criticised for multiple sclerosis manoeuvres

November 2, 2012
Sales and Marketing Cancer, Lemtrada, MS, Sanofi

Sanofi is facing a backlash as it prepares its new MS treatment for the market. Lemtrada (alemtuzumab) has produced very …

News

Genzyme ‘confident’ of FDA nod for MS drug

August 29, 2012
Sales and Marketing Genzyme, Lemtrada, MS, multiple sclerosis

Genzyme insists it is on course to resubmit an existing oncology drug for the treatment of relapsing multiple sclerosis (RMS), …

News

Sanofi submits key MS pill for approval

June 12, 2012
Research and Development, Sales and Marketing Bayer, EMA, FDA, Genzyme, Lemtrada, MS, Sanofi

Sanofi has submitted its multiple sclerosis pill Lemtrada for regulatory reviews in the US and Europe. Lemtrada (alemtuzumab), originally developed …

News

Sanofi’s Lemtrada beats Rebif in new study

November 14, 2011
Research and Development, Sales and Marketing Lemtrada, Rebif, Sanofi

Lemtrada has beaten Merck Serono’s multiple sclerosis treatment Rebif in a new head-to-head trial, paving the way for regulatory submission …

News
The Gateway to Local Adoption Series

Latest content

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026

Rare diseases – spinal muscular atrophy

January 30, 2026

Could targeting the molecular causes of infertility finally transform IVF success rates?

January 29, 2026

Digital mental health technologies – a valuable tool in supporting people with depression and anxiety

January 29, 2026

Barts Health NHS Trust collaborates with H.I.G. Realty on healthcare innovation building

January 29, 2026